•   
  •   
  •   

Sport An eleventh vaccine against Covid-19, by Novavax, enters phase 3 of clinical trials

02:05  25 september  2020
02:05  25 september  2020 Source:   ouest-france.fr

Poll: Number of Americans willing to get a vaccination falls as fears mount that Trump is putting politics before safety

  Poll: Number of Americans willing to get a vaccination falls as fears mount that Trump is putting politics before safety Now, four months later, less than a third of Americans (32 percent) say they plan to get vaccinated, according to the latest Yahoo News/YouGov poll — a stunning 23-point decline that reflects rising concern about the politicization of the vaccine process and underscores how challenging it will be to stop the pandemic through vaccination alone. As recently as late July, 42 percent of Americans had said they planned to get vaccinated, meaning 10 percent of the public has moved into the “no” or “not sure” column over the last month or so. © Provided by Yahoo! News The question is why.

Five other coronavirus vaccines are already in Phase 3 trials , in which thousands of people are Although Novavax is the first company to share clinical results on the immune response of a protein Dr. Moore speculated that the best vaccine against Covid - 19 might marshal both types of responses.

A Phase 3 clinical trial designed to evaluate if an investigational vaccine can prevent symptomatic coronavirus disease 2019 ( COVID - 19 ) in adults has “Operation Warp Speed is supporting a portfolio of vaccines like the NIH/Moderna candidate so that, if the results of clinical trials meet FDA’s gold

C'est le onzième vaccin expérimental dans le monde à entrer dans la dernière phase des essais cliniques. © AFP / ANDREW CABALLERO-REYNOLDS It is the eleventh experimental vaccine in the world to enter the last phase of clinical trials .

A new experimental vaccine against Covid-19 enters the final phase of testing. The trial aims to include 10,000 participants aged 18 to 84.

US biotechnology company Novavax announced on Thursday that it has started a final phase clinical trial in UK of its experimental vaccine against Covid-19 .

The trial aims to include 10,000 participants aged 18 to 84.

“Due to the current high level of SARS-CoV-2 transmissions, and given that it will likely continue to be high in the UK, we are optimistic that the clinical trial will benefit from rapid recruitment and produce Short-term results of the ' vaccine's efficacy from Novavax, said in a statement Gregory Glenn, director of research and development.

Trump says CDC Director Robert Redfield 'confused' about coronavirus vaccine, mask efficacy. Redfield responded.

  Trump says CDC Director Robert Redfield 'confused' about coronavirus vaccine, mask efficacy. Redfield responded. Donald Trump took issue with CDC director Robert Redfield's comments that face masks are more effective than a vaccine at stopping spread of COVID.Hurricane Sally power outages top 540,000 in Alabama, Florida and Georgia

Novavax , Inc. is a clinical -stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our Commitment in the Fight Against COVID - 19 . Novavax is proud to be at the forefront of the fight against this urgent global healthcare crisis.

Dr. Richard Hatchett, CEO of CEPI said, “ Entering clinical trials is an important step on the path to delivering a safe Novavax recently initiated development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID - 19 , with Phase 1 clinical trial results expected in

Eleventh experimental vaccine in the world

It is the eleventh experimental vaccine in the world to enter the last phase of clinical trials, on tens of thousands of participants, of whom generally half receive a placebo and the other half the vaccine.

The most advanced Western projects are those developed by AstraZeneca, partner of Oxford University, Pfizer and Moderna. Chinese and Russian projects have also reached the final phase of testing.

Novavax is one of six companies funded to the tune of several hundred million dollars by the US government, and the fifth to enter Phase 3. It has received more than $ 1.6 billion in US public money for finance the production of 100 million doses.

Analyst: Selloff was a mistake on this "virus" share .
The shares of the US vaccine manufacturer Novavax have been badly damaged in recent weeks. But Mayank Mamtani, an analyst at B. Riley FBR, is still convinced of the stock and assumes that the price will more than double. © Provided by Finanz.net KAZUHIRO NOGI / AFP / GettyImages • Still "Buy" for Novavax • Price doubling expected • Focus on production capacity for vaccine The US biotech company Novavax is currently testing its experimental coronavirus vaccine NVX- CoV2373 on test subjects.

—   Share news in the SOC. Networks
usr: 0
This is interesting!